Parkinson's Disease Mechanisms and Treatments

146 та иш

Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations
Jamoliddin Razzokov, Sunnatullo Fazliev, Mukhriddin Makhkamov +3
МақолаParkinson's Disease Mechanisms and TreatmentsInternational Journal of Molecular Sciences20235 иқтибос
ABI
Hormonal pathogenetic effects and vascular-immunological aspects in secondary vascular parkinsonism
D. Akramova, G. Rakhimbaeva
МақолаNuclear Receptors and SignalingParkinsonism & Related Disorders20181 иқтибос
ABI
New methods of treatment for vascular Parkinsonism and Parkinson's disease: Tempo-rhythmal correction combined with special exercise and music
D. Akramova, G. Rakhimbaeva
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Role of increased levels of endothelial factors in cognitive impairment in the Parkinson’s disease and vascular parkinsonism
D. Akramova, G. Rakhimbaeva
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Metabolically induced intracellular pH changes activate mitophagy, autophagy, and cell protection in familial forms of Parkinson's disease
Nafisa R. Komilova, Plamena R. Angelova, Alexey V. Berezhnov +6
МақолаAutophagy in Disease and TherapyFEBS Journal20211 иқтибос
ABI
EVALUATION OF PRODROMAL STAGE BIOMARKERS IN PARKINSON'S DISEASE AND THEIR ROLE IN DISEASE PROGRESSION USE OF MODERN DIGITAL TECHNOLOGIES
Khilola Maratovna Daminova, R. Matmurodov, D. Akramova +7
МақолаParkinson's Disease Mechanisms and Treatments20221 иқтибос
ABI
Exploring α-synuclein stability under the external electrostatic field: Effect of repeat unit
Javokhir Khursandov, Rasulbek Mashalov, Mukhriddin Makhkamov +3
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of Structural Biology20241 иқтибос
ABI
The influence of robotics and modern technologies to assist individuals with Parkinson's disease
A. Kim, L. Alimbekova
МақолаNeurological disorders and treatmentsParkinsonism & Related Disorders20241 иқтибос
ABI
Initial manifestations of Parkinson's disease in Uzbek nationality
R. Juraev, E. Abdukodirov, R. Matmurodov +1
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Gastrointestinal disturbances in various forms of parkinsonism
O. Naimov, R. Matmurodov, E. Abdukodirov
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Cardiovascular disorders in parkinsonism depending on the form of the disease
R. Matmurodov, K. Khalimova, E. Abdukodirov
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Constipation as a predictor of Parkinson's disease in persons of Uzbek nationality
O. Naimov, E. Abdukodirov, R. Matmurodov +1
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Character changes as a predictor of Parkinson’s disease in persons of Uzbek nationality
R. Matmurodov, K. Khalimova, E. Abdukodirov
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 иқтибос
ABI
Sleep disorders as a predictor of Parkinson's disease in Uzbek nationality
B. Amonov, Rustambek Matmurodov, E. Abdukodirov +1
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20211 иқтибос
ABI
Psychosis in a Case of Schizophrenia and Parkinson’s Disease
Benedikt Habermeyer, Stefan Kneifel, Irene Lotz-Bläuer +1
БошқаNeurological disorders and treatmentsJournal of Neuropsychiatry20080 иқтибос
ABI
α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease
Masaaki Waragai, Kazunari Sekiyama, Akio Sekigawa +3
Шарҳ мақолаParkinson's Disease Mechanisms and TreatmentsInternational Journal of Molecular Sciences20100 иқтибос
ABI
Akiramine
Shakhnoza S. Azimova, Marat S. Yunusov
БобParkinson's Disease Mechanisms and Treatments20120 иқтибос
ABI
Norbracteoline
Shakhnoza S. Azimova, Marat S. Yunusov
БобCancer Treatment and Pharmacology20120 иқтибос
ABI
14-Dehydrotalatisamine
Shakhnoza S. Azimova, Marat S. Yunusov
БобParkinson's Disease Mechanisms and Treatments20120 иқтибос
ABI
Cyclolicorisoflavan-A
Shakhnoza S. Azimova, Valentina I. Vinogradova
БобParkinson's Disease Mechanisms and Treatments20120 иқтибос
ABI
Ungeremine (Licobetaine)
Shakhnoza S. Azimova, Marat S. Yunusov
БобPharmacology and Obesity Treatment20120 иқтибос
ABI
Violation of metabolism of nitric oxide in patients with Parkinson's disease and vascular parkinsonism
Rustambek Matmurodov, K. Khalimova, M.M. Raimova
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20130 иқтибос
ABI
Estimation of the caused skin vegetative potentials in patients with Parkinson's disease
Y.N. Madjidova, S.R. Fahargalieva
МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20130 иқтибос
ABI
The importance of Ishihara Testing in early diagnosing of Parkinson disease
S. Mirdedaev
МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20150 иқтибос
ABI
EEG features of dyskinesias, complicated by levodopa therapy in patients with Parkinson's disease.
Ulugbek Askhonov, Bahtiyar Gafurov, Gulomqodir Ashanov
МақолаAttention Deficit Hyperactivity DisorderParkinsonism & Related Disorders20150 иқтибос
ABI